Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Orion Corporation: Organising meeting of the Board of Directors | ||||||
By: GlobeNewswire - 20 Mar 2024 | Back to overview list |
|||||
ORION CORPORATION In its organising meeting, the Board of Directors of Orion Corporation, which was elected today by the Annual General Meeting of the Shareholders, has elected Hilpi Rautelin as Vice Chairman. The compositions of the Board committees were decided to be as follows: Personnel and Remuneration Committee: Veli-Matti Mattila, Chairman Audit Committee: Ari Lehtoranta, Chairman R&D Committee: Hilpi Rautelin, Chairman The Company also has a Nomination Committee, the election of which was announced in a Stock Exchange Release on 28 April 2023. All members of the Board of Directors have been assessed to be independent of the company and its significant shareholders. Orion Corporation
tel. +358 50 966 3054 Publisher: Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2023 amounted to EUR 1,190 million and the company had about 3,600 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki. |
||||||
|
||||||
Copyright 2024 GlobeNewswire | Back to overview list |